Clinical trial
Radium-223 Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients with Bone Metastasis
To assess acute and long-term safety and overall survival in patients with castration-resistant (hormone-refractory) prostate cancer.
| Category | Value |
|---|---|
| Study start date | 2012-06-12 |